This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Prognosis of kidney cancer

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • Half (50%) of people diagnosed with kidney cancer in England and Wales survive their disease for ten years or more (2010-11)

  • Almost 6 in 10 (56%) people diagnosed with kidney cancer in England and Wales survive their disease for five years or more (2010-11)

  • More than 7 in 10 (72%) people diagnosed with kidney cancer in England and Wales survive their disease for one year or more (2010-11)

  • Kidney cancer survival is higher in men than women at one- and five-years but similar at ten-years

  • Kidney cancer survival in England is highest for people diagnosed aged under 50 years old (2009-2013)

  • Around three-quarters of people in England diagnosed with Kidney cancer aged 15-49 survive their disease for five years or more, compared with more than a third of people diagnosed aged 80 and over (2009-2013)

  • Kidney cancer survival is improving and has increased in the last 40 years in the UK

 

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.